QA: ENZO Biochem INC in us_health_services/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000316253_2017_ENZO_Biochem_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.008121497604158206, 'aggregate_val': 24826000, 'exp_sum': 24626000, 'exp_to_value': {'LongTermLiabilities': 774000, 'LiabilitiesCurrent': 23852000, 'remainder_Liabilities': 0}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.006708702984089742, 'aggregate_val': 27461000, 'exp_sum': 27278000, 'exp_to_value': {'LongTermLiabilities': 2313000, 'LiabilitiesCurrent': 24965000, 'remainder_Liabilities': 0}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000316253, ENZO Biochem INC

  xvar xval
0 IntangibleAssets 11,874,000
1 AssetsNonCurrent 336,000
2 AssetsCurrent 91,397,000
3 PropertyPlantAndEquipment 8,214,000
4 remainder_Assets 0
5 LongTermLiabilities 1,699,000
6 LiabilitiesCurrent 20,568,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 0
10 GeneralAndAdministrativeExpense 43,586,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 3,524,000
16 remainder_Expenses 9,889,000
17 remainder_Revenues 102,773,000
18 remainder_NetIncome -488,000
19 remainder_ComprehensiveNetIncome 338,000
  yvar yval
0 Assets 111,821,000
1 Liabilities 22,267,000
2 Expenses 56,999,000
3 Revenues 102,773,000
4 StockholdersEquity 89,554,000
5 NetIncome 45,286,000
6 ComprehensiveNetIncome 45,624,000
7 BaseVar 147,343,000
8 EconomicCapitalRatio 4.39

Edgar->Model Mapping

Feature Distribution

Change over Time